Zoom Webinar on Guidance for VITT following J & J COVID-19 Vaccination
Please join the American Society of Hematology as they share guidance on diagnosis and management of suspected Vaccine-induced Immune Thrombotic Thrombocytopenia (VITT) following Johnson & Johnson (Janssen) COVID-19 Vaccination.
Hosted by the Centers for Disease Control and Prevention (CDC).
You are invited to a Zoom webinar.
When: Tuesday, April 20, 2021, 1:00 PM Eastern Time
Description: Rare cases of thrombosis with thrombocytopenia have been reported following vaccination with the Johnson & Johnson/Janssen COVID-19 vaccine. This one-hour seminar will review the background, diagnosis, and clinical management of this emerging disorder with experts from CDC and the American Society of Hematology, as well as how to report cases through CDC’s Vaccine Adverse Events Reporting System (VAERS).
Speakers:
John T. Brooks, MD
Centers for Disease Control and Prevention (CDC)
Chief Medical Officer, CDC COVID-19 Response
John R. Su, MD, PhD, MPH
Centers for Disease Control and Prevention (CDC)
Vaccine Safety Team, CDC COVID-19 Response
Lisa Baumann Kreuziger, MD, MS
Associate Investigator, Blood Research Institute, Versiti
Associate Professor, Hematology & Oncology, Medical College of Wisconsin
Jean Marie Connors, MD
Medical Director, Anticoagulation Management and Stewardship Services Hematology Division
Brigham and Women’s Hospital/Dana Farber Cancer Institute
Please click the link below to join the webinar:
Passcode: 810423
Or One tap mobile:
US: +16692545252,,1600672158#,,,,*810423# or +16468287666,,1600672158#,,,,*810423#
Or Telephone:
US: +1 669 254 5252 or +1 646 828 7666 or +1 551 285 1373 or +1 669 216 1590
Webinar ID: 160 067 2158
Passcode: 810423
Or an H.323/SIP room system:
H.323: 161.199.138.10 (US West) or 161.199.136.10 (US East)
Meeting ID: 160 067 2158
Passcode: 810423
Passcode: 810423
Due to the large number of participants, the live question and chat feature will be disabled.
